Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 2 (2005), Issue 8 (August)

1. Comparison of efficacy of implanted cardioverter-defibrillator in patients with versus without diabetes mellitus.
   Am J Cardiol, 96(3): 417-9. [Abstract] [Full-text]
2. Frequency of undiagnosed diabetes mellitus in patients with acute coronary syndrome.
   Am J Cardiol, 96(3): 363-5. [Abstract] [Full-text]
3. Comparison of short- (one month) and long- (twelve months) term outcomes of sirolimus- versus paclitaxel-eluting stents in 293 consecutive patients with diabetes mellitus (from the RESEARCH and T-SEARCH registries).
   Am J Cardiol, 96(3): 358-62. [Abstract] [Full-text]
4. The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse.
   Cell Metab, 1(4): 245-58. [Abstract] [Full-text]
5. A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes.
   Cell Metab, 1(2): 133-44. [Abstract] [Full-text]
6. Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes.
   Cell Metab, 1(2): 107-19. [Abstract] [Full-text]
7. Why Syndrome X? From Harold Himsworth to the insulin resistance syndrome.
   Cell Metab, 1(1): 9-14. [Abstract] [Full-text]
8. The effect of insulin deficiency on tau and neurofilament in the insulin knockout mouse.
   Biochem Biophys Res Commun, 334(4): 979-86. [Abstract] [Full-text]
9. A short-term diabetes induced changes of catecholamines and p38-MAPK in discrete areas of rat brain.
   Life Sci, 77(15): 1825-35. [Abstract] [Full-text]
10. ABCA1, ApoA-I and type II DM.
    Biochem Biophys Res Commun, 334(4): 971-2. [Abstract] [Full-text]
11. Type 2 diabetes--therapy with dipeptidyl peptidase IV inhibitors.
    Biochim Biophys Acta, 1751(1): 33-44. [Abstract] [Full-text]
12. How viral infections affect the autoimmune process leading to type 1 diabetes.
    Cell Immunol, 233(2): 125-32. [Abstract] [Full-text]
13. Evaluation of SLC2A10 (GLUT10) as a candidate gene for type 2 diabetes and related traits in Finns.
    Mol Genet Metab, 85(4): 323-7. [Abstract] [Full-text]
14. Thymoquinone reduces hepatic glucose production in diabetic hamsters.
    Res Vet Sci, 79(3): 219-23. [Abstract] [Full-text]
15. Effects of internal limiting membrane peeling in vitrectomy on diabetic cystoid macular edema patients.
    Jpn J Ophthalmol, 49(4): 297-300. [Abstract] [Full-text]
16. Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity.
    J Clin Invest, 115(8): 2268-76. [Abstract] [Full-text]
17. A molecule's right to choose: how diabetogenic class II MHC products bind peptides.
    J Clin Invest, 115(8): 2077-9. [Abstract] [Full-text]
18. ATP-sensitive potassium channelopathies: focus on insulin secretion.
    J Clin Invest, 115(8): 2047-58. [Abstract] [Full-text]
19. ADVANCE: action in diabetes and vascular disease.
    J Hum Hypertens, 19: S27-32. [Abstract] [Full-text]
20. New concepts in blood pressure-lowering management in diabetic patients: the case for early ACE inhibitor combination therapy with diuretics.
    J Hum Hypertens, 19: S15-20. [Abstract] [Full-text]
21. Subtle hyperproinsulinaemia characterises the defective insulin secretory capacity in offspring of glutamic acid decarboxylase antibody-positive patients with latent autoimmune diabetes mellitus in adults.
    Eur J Endocrinol, 153(2): 265-73. [Abstract] [Full-text]
22. Cocarcinogenic effects of islet hormones and N-nitrosomorpholine in hepatocarcinogenesis after intrahepatic transplantation of pancreatic islets in streptozotocin-diabetic rats.
    Cancer Res, 65(15): 7013-22. [Abstract] [Full-text]
23. Medicare chronic care improvement program puts the spotlight on case management.
    Case Manager, 16(4): 56-8. [Abstract] [Full-text]
24. Diabetes mellitus and cardiothoracic surgical site infections.
    Am J Infect Control, 33(6): 353-9. [Abstract] [Full-text]
25. Bitter gourd (Momordica charantia) modulates activities of intestinal and renal disaccharidases in streptozotocin-induced diabetic rats.
    Mol Nutr Food Res, 49(8): 791-6. [Abstract] [Full-text]
26. Alms1-disrupted mice recapitulate human Alström syndrome.
    Hum Mol Genet, 14(16): 2323-33. [Abstract] [Full-text]
27. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
    Scand J Clin Lab Invest, 65(4): 307-20. [Abstract] [Full-text]
28. Monozygous triplets discordant for transient neonatal diabetes mellitus and for imprinting of the TNDM differentially methylated region.
    Hum Genet, 117(4): 398-401. [Abstract] [Full-text]
29. IGF-I-induced enhancement of contractile response in organ-cultured aortae from diabetic rats is mediated by sustained thromboxane A2 release from endothelial cells.
    J Endocrinol, 186(2): 367-76. [Abstract] [Full-text]
30. Teleconferenced educational detailing: diabetes education for primary care physicians.
    J Contin Educ Health Prof, 25(2): 87-97. [Abstract] [Full-text]
31. Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes.
    Methods Find Exp Clin Pharmacol, 27(5): 289-304. [Abstract] [Full-text]
32. NOD mice and autoimmunity.
    Autoimmun Rev, 4(6): 373-9. [Abstract] [Full-text]
33. Role of protein kinase C on the alteration of retinal endothelin-1 in streptozotocin-induced diabetic rats.
    Exp Eye Res, 81(2): 200-6. [Abstract] [Full-text]
34. Proteomic analysis of vitreous from diabetic macular edema.
    Exp Eye Res, 81(2): 176-82. [Abstract] [Full-text]
35. Age and gender related effects on adipose tissue compartments of subjects with increased risk for type 2 diabetes: a whole body MRI/MRS study.
    MAGMA, 18(3): 128-37. [Abstract] [Full-text]
36. The impact of diabetes on patient outcomes after ankle fracture.
    J Bone Joint Surg Am, 87(8): 1712-8. [Abstract] [Full-text]
37. Clinical comorbidity was specific to disease pathology, psychologic distress, and somatic symptom amplification.
    J Clin Epidemiol, 58(9): 909-17. [Abstract] [Full-text]
38. Type 2 diabetes in children and youth.
    Endocrinol Metab Clin North Am, 34(3): 659-76, ix-x. [Abstract] [Full-text]
39. Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma2 gene on rosiglitazone response in type 2 diabetes.
    Clin Pharmacol Ther, 78(2): 202-8. [Abstract] [Full-text]
40. Mood disorders in the medically ill: scientific review and recommendations.
    Biol Psychiatry, 58(3): 175-89. [Abstract] [Full-text]
41. Disability and quality of life in Canadian aboriginal and non-aboriginal diabetic lower-extremity amputees.
    Arch Phys Med Rehabil, 86(8): 1594-602. [Abstract] [Full-text]
42. The relative benefits of endurance and strength training on the metabolic factors and muscle function of people with type 2 diabetes mellitus.
    Arch Phys Med Rehabil, 86(8): 1527-33. [Abstract] [Full-text]
43. Probability of pancreatic cancer following diabetes: a population-based study.
    Gastroenterology, 129(2): 504-11. [Abstract] [Full-text]
44. The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes.
    Growth Horm IGF Res, 15(4): 304-10. [Abstract] [Full-text]
45. Visfatin: the missing link between intra-abdominal obesity and diabetes?
    Trends Mol Med, 11(8): 344-7. [Abstract] [Full-text]
46. Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose.
    Growth Horm IGF Res, 15(4): 265-74. [Abstract] [Full-text]
47. Effects of cyclohexenonic long-chain fatty alcohol on diabetic rat trachea.
    Life Sci, 77(16): 2030-9. [Abstract] [Full-text]
48. Vitrectomy for diabetic macular edema with and without internal limiting membrane removal.
    Ophthalmologica, 219(4): 206-13. [Abstract] [Full-text]
49. High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction.
    J Mol Endocrinol, 35(1): 39-48. [Abstract] [Full-text]
50. Effects of glucagon-like peptide-1 and exendins on kinase activity, glucose transport and lipid metabolism in adipocytes from normal and type-2 diabetic rats.
    J Mol Endocrinol, 35(1): 27-38. [Abstract] [Full-text]
51. Glomerular structural changes in pregnant, diabetic, and pregnant-diabetic rats.
    APMIS, 113(7): 465-72. [Abstract] [Full-text]
52. Functional properties of the stratum corneum in patients with diabetes mellitus: similarities to senile xerosis.
    Br J Dermatol, 153(2): 319-23. [Abstract] [Full-text]
53. Vitrectomy for persistent diffuse diabetic macular edema.
    Am J Ophthalmol, 140(2): 295-301. [Abstract] [Full-text]
54. Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema.
    Am J Ophthalmol, 140(2): 251-5. [Abstract] [Full-text]
55. Visual outcome and risk factors for light perception and no light perception vision after vitrectomy for diabetic retinopathy.
    Am J Ophthalmol, 140(2): 231-5. [Abstract] [Full-text]
56. Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression.
    J Clin Endocrinol Metab, 90(8): 4510-5. [Abstract] [Full-text]
57. Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes.
    J Clin Endocrinol Metab, 90(8): 4904-11. [Abstract] [Full-text]
58. Half of clinically defined maturity-onset diabetes of the young patients in Denmark do not have mutations in HNF4A, GCK, and TCF1.
    J Clin Endocrinol Metab, 90(8): 4607-14. [Abstract] [Full-text]
59. Diabetes-induced renal vascular dysfunction is normalized by inhibition of epidermal growth factor receptor tyrosine kinase.
    J Vasc Res, 42(4): 284-91. [Abstract] [Full-text]
60. High prevalence of glucose-6-phosphate dehydrogenase deficiency without gene mutation suggests a novel genetic mechanism predisposing to ketosis-prone diabetes.
    J Clin Endocrinol Metab, 90(8): 4446-51. [Abstract] [Full-text]
61. Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes.
    J Clin Endocrinol Metab, 90(8): 4542-8. [Abstract] [Full-text]
62. Effect of insulin on plasma vascular endothelial growth factor in children with new-onset diabetes.
    J Clin Endocrinol Metab, 90(8): 4920-3. [Abstract] [Full-text]
63. Insulin-induced hypoglycemia accelerates gastric emptying of solids and liquids in long-standing type 1 diabetes.
    J Clin Endocrinol Metab, 90(8): 4489-95. [Abstract] [Full-text]
64. CLINICAL REVIEW: Use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy.
    J Clin Endocrinol Metab, 90(8): 4936-45. [Abstract] [Full-text]
65. Association between a protein polymorphism in the start codon of the vitamin D receptor gene and severe diabetic retinopathy in C-peptide-negative type 1 diabetes.
    J Clin Endocrinol Metab, 90(8): 4803-8. [Abstract] [Full-text]
66. Increased transvascular lipoprotein transport in diabetes: association with albuminuria and systolic hypertension.
    J Clin Endocrinol Metab, 90(8): 4441-5. [Abstract] [Full-text]
67. Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes.
    J Clin Endocrinol Metab, 90(8): 4888-94. [Abstract] [Full-text]
68. Metabolic syndrome at follow-up in women with and without gestational diabetes mellitus in index pregnancy.
    Metabolism, 54(8): 1115-21. [Abstract] [Full-text]
69. Relationship between blood lactate concentration and substrate utilization during exercise in type 2 diabetic postmenopausal women.
    Metabolism, 54(8): 1102-7. [Abstract] [Full-text]
70. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes.
    Metabolism, 54(8): 1020-6. [Abstract] [Full-text]
71. Brain glucose concentrations in poorly controlled diabetes mellitus as measured by high-field magnetic resonance spectroscopy.
    Metabolism, 54(8): 1008-13. [Abstract] [Full-text]
72. A novel advanced glycation index and its association with diabetes and microangiopathy.
    Metabolism, 54(8): 1002-7. [Abstract] [Full-text]
73. Effect of a single vs multiple bouts of exercise on glucose control in women with type 2 diabetes.
    Metabolism, 54(8): 989-94. [Abstract] [Full-text]
74. IPF-1/MODY4 gene missense mutation in an Italian family with type 2 and gestational diabetes.
    Metabolism, 54(8): 983-8. [Abstract] [Full-text]
75. Enterovirus RNA sequences in sera of schoolchildren in the general population and their association with type 1-diabetes-associated autoantibodies.
    J Med Microbiol, 54: 879-83. [Abstract] [Full-text]
76. Usefulness of the addition of metformin to insulin in pediatric patients with type 1 diabetes mellitus.
    Pediatr Int, 47(4): 430-3. [Abstract] [Full-text]
77. Neuronal deletion of Lepr elicits diabesity in mice without affecting cold tolerance or fertility.
    Am J Physiol Endocrinol Metab, 289(3): E403-11. [Abstract] [Full-text]
78. Vasopressin increases urea permeability in the initial IMCD from diabetic rats.
    Am J Physiol Renal Physiol, 289(3): F531-5. [Abstract] [Full-text]
79. Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy.
    Am J Physiol Renal Physiol, 289(3): F544-51. [Abstract] [Full-text]
80. Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes.
    Cell, 122(3): 337-49. [Abstract] [Full-text]
81. The effect of short duration streptozotocin-induced diabetes mellitus on the late phase and threshold of long-term potentiation induction in the rat.
    Brain Res, 1053(1): 126-30. [Abstract] [Full-text]
82. Cerebral ischemia induced apoptosis and necrosis in normal and diabetic rats.
    Brain Res, 1053(1): 1-9. [Abstract] [Full-text]
83. Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy.
    Diabetologia, 48(8): 1637-44. [Abstract] [Full-text]
84. Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition.
    Diabetologia, 48(8): 1645-53. [Abstract] [Full-text]
85. Wheat protein-induced proinflammatory T helper 1 bias in mesenteric lymph nodes of young diabetes-prone rats.
    Diabetologia, 48(8): 1576-84. [Abstract] [Full-text]
86. Lack of effect of intermittently administered sodium fusidate in patients with newly diagnosed type 1 diabetes mellitus: the FUSIDM trial.
    Diabetologia, 48(8): 1464-8. [Abstract] [Full-text]
87. Diabetes-associated HLA genotypes affect birthweight in the general population.
    Diabetologia, 48(8): 1484-91. [Abstract] [Full-text]
88. Pancreatic beta and alpha cells are both decreased in patients with fulminant type 1 diabetes: a morphometrical assessment.
    Diabetologia, 48(8): 1560-4. [Abstract] [Full-text]
89. Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapy.
    Diabetologia, 48(8): 1585-9. [Abstract] [Full-text]
90. Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes.
    Diabetologia, 48(8): 1590-603. [Abstract] [Full-text]
91. Implantation of primary cultured adipocytes that secrete insulin modifies blood glucose levels in diabetic mice.
    Diabetologia, 48(8): 1614-20. [Abstract] [Full-text]
92. Influence of Pro12Ala peroxisome proliferator-activated receptor gamma2 polymorphism on glucose response to exercise training in type 2 diabetes.
    Diabetologia, 48(8): 1503-9. [Abstract] [Full-text]
93. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse.
    Diabetologia, 48(8): 1565-75. [Abstract] [Full-text]
94. The changing epidemiology of diabetic microangiopathy in type 1 diabetes.
    Diabetologia, 48(8): 1439-44. [Abstract] [Full-text]
95. Retinal neovascularisation without ischaemia in the spontaneously diabetic Torii rat.
    Diabetologia, 48(8): 1663-8. [Abstract] [Full-text]
96. Increased augmentation of central blood pressure is associated with increases in carotid intima-media thickness in type 2 diabetic patients.
    Diabetologia, 48(8): 1654-62. [Abstract] [Full-text]
97. A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes.
    Diabetologia, 48(8): 1469-76. [Abstract] [Full-text]
98. Urinary sodium and potassium excretion and the risk of type 2 diabetes: a prospective study in Finland.
    Diabetologia, 48(8): 1477-83. [Abstract] [Full-text]
99. Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment?
    Diabetologia, 48(8): 1445-53. [Abstract] [Full-text]
100. The -174 IL-6 GG genotype is associated with a reduced risk of type 2 diabetes mellitus in a family sample from the National Heart, Lung and Blood Institute's Framingham Heart Study.
     Diabetologia, 48(8): 1492-5. [Abstract] [Full-text]
101. Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus.
     J Hum Genet, 50(6): 283-92. [Abstract] [Full-text]
102. The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: a meta-analysis.
     J Hum Genet, 50(6): 267-75. [Abstract] [Full-text]
103. Case study: contrasting challenges of insulin pump therapy in a toddler and adolescent with type 1 diabetes.
     Diabetes Educ, 31(4): 584-90. [Abstract] [Full-text]
104. Disordered eating behaviors in youth with type 1 diabetes.
     Diabetes Educ, 31(4): 572-83. [Abstract] [Full-text]
105. Clinical inertia contributes to poor diabetes control in a primary care setting.
     Diabetes Educ, 31(4): 564-71. [Abstract] [Full-text]
106. Soul food light: culturally competent diabetes education.
     Diabetes Educ, 31(4): 555-63. [Abstract] [Full-text]
107. Symptom prevalence and treatments among mexican americans with type 2 diabetes.
     Diabetes Educ, 31(4): 543-54. [Abstract] [Full-text]
108. Practical management of patients with painful diabetic neuropathy.
     Diabetes Educ, 31(4): 523-4, 526-8, 530 passim. [Abstract] [Full-text]
109. Choosing and using theories in diabetes education research.
     Diabetes Educ, 31(4): 513, 515, 518-20. [Abstract] [Full-text]
110. The Charcot foot: a clinical challenge.
     Int J Low Extrem Wounds, 4(3): 183-7. [Abstract] [Full-text]
111. Diabetic foot complications: diagnosis and management.
     Int J Low Extrem Wounds, 4(3): 171-82. [Abstract] [Full-text]
112. A review of the biomechanics of the diabetic foot.
     Int J Low Extrem Wounds, 4(3): 160-70. [Abstract] [Full-text]
113. A review of the mechanisms implicated in the pathogenesis of the diabetic foot.
     Int J Low Extrem Wounds, 4(3): 154-9. [Abstract] [Full-text]
114. Infection in the neuroischemic foot.
     Int J Low Extrem Wounds, 4(3): 145-53. [Abstract] [Full-text]
115. Abnormalities of vasomotor regulation in the pathogenesis of the acute charcot foot of diabetes mellitus.
     Int J Low Extrem Wounds, 4(3): 133-7. [Abstract] [Full-text]
116. Predictive performance of anthropometric indexes of central obesity for the risk of type 2 diabetes.
     Arch Med Res, 36(5): 581-9. [Abstract] [Full-text]
117. Plasma prekallikrein as a risk factor for diabetic retinopathy.
     Arch Med Res, 36(5): 539-43. [Abstract] [Full-text]
118. Auditory impairment in patients with type 2 diabetes mellitus.
     Arch Med Res, 36(5): 507-10. [Abstract] [Full-text]
119. Venodynamic and hemorheological variables in patients with diabetes mellitus.
     Arch Med Res, 36(5): 490-5. [Abstract] [Full-text]
120. A case of type 2 diabetes with a large abscess of the gastric wall successfully treated with a glycemic control and systemic antibiotics.
     Diabetes Res Clin Pract, 69(3): 299-304. [Abstract] [Full-text]
121. Diabetes worsens the outcome of acute ischemic stroke.
     Diabetes Res Clin Pract, 69(3): 293-8. [Abstract] [Full-text]
122. WRN gene 1367 Arg allele protects against development of type 2 diabetes mellitus.
     Diabetes Res Clin Pract, 69(3): 287-92. [Abstract] [Full-text]
123. Gestational diabetes in Iran: incidence, risk factors and pregnancy outcomes.
     Diabetes Res Clin Pract, 69(3): 279-86. [Abstract] [Full-text]
124. N-(carboxymethyl)valine residues in hemoglobin (CMV-Hb) reflect accumulation of oxidative stress in diabetic patients.
     Diabetes Res Clin Pract, 69(3): 272-8. [Abstract] [Full-text]
125. Hospital admission for selected single virus infections prior to diabetes mellitus.
     Diabetes Res Clin Pract, 69(3): 256-61. [Abstract] [Full-text]
126. Clinical features of non-diabetic renal diseases in patients with type 2 diabetes.
     Diabetes Res Clin Pract, 69(3): 237-42. [Abstract] [Full-text]
127. IL-15 is elevated in serum patients with type 1 diabetes mellitus.
     Diabetes Res Clin Pract, 69(3): 231-6. [Abstract] [Full-text]
128. Suspicion and treatment of the macrosomic fetus: a review.
     Am J Obstet Gynecol, 193(2): 332-46. [Abstract] [Full-text]
129. An approach to heart failure and diabetes mellitus.
     Am J Cardiol, 96(4): 47E-52E. [Abstract] [Full-text]
130. Systematic strategies for improved outcomes for the hyperglycemic hospitalized patient with diabetes mellitus.
     Am J Cardiol, 96(4): 41E-46E. [Abstract] [Full-text]
131. Basic approach to managing hyperglycemia for the nonendocrinologist.
     Am J Cardiol, 96(4): 37E-40E. [Abstract] [Full-text]
132. Rationale for new American Diabetes Association Guidelines: are national cholesterol education program goals adequate for the patient with diabetes mellitus?
     Am J Cardiol, 96(4): 33E-36E. [Abstract] [Full-text]
133. Lipid management in patients with diabetes mellitus.
     Am J Cardiol, 96(4): 26E-32E. [Abstract] [Full-text]
134. Assessing risk across the spectrum of patients with the metabolic syndrome.
     Am J Cardiol, 96(4): 8E-10E. [Abstract] [Full-text]
135. Implications of the metabolic syndrome: the new epidemic.
     Am J Cardiol, 96(4): 3E-7E. [Abstract] [Full-text]
136. Diabetic pancreatic beta cells ARNT all they should be.
     Cell Metab, 2(2): 78-80. [Abstract] [Full-text]
137. Relation of elevated periprocedural blood glucose to long-term survival after percutaneous coronary intervention.
     Am J Cardiol, 96(4): 543-6. [Abstract] [Full-text]
138. Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes.
     Biochem Biophys Res Commun, 335(2): 596-602. [Abstract] [Full-text]
139. Evidence for an enhanced adhesion of DC to fibronectin and a role of CCL19 and CCL21 in the accumulation of DC around the pre-diabetic islets in NOD mice.
     Eur J Immunol, 35(8): 2386-96. [Abstract] [Full-text]
140. Depressive symptoms of type 2 diabetics treated with insulin compared to diabetics taking oral anti-diabetic drugs: a Korean study.
     Diabetes Res Clin Pract, 69(3): 243-8. [Abstract] [Full-text]
141. Type 2 diabetes mellitus, its treatment and risk for lymphoma.
     Eur J Cancer, 41(12): 1782-7. [Abstract] [Full-text]
142. Accelerated glucose intolerance, nephropathy, and atherosclerosis in prostaglandin D2 synthase knock-out mice.
     J Biol Chem, 280(33): 29946-55. [Abstract] [Full-text]
143. Mechanisms of oleic acid deterioration in insulin secretion: role in the pathogenesis of type 2 diabetes.
     Life Sci, 77(17): 2071-81. [Abstract] [Full-text]
144. Leptin resistance extends to the coronary vasculature in prediabetic dogs and provides a protective adaptation against endothelial dysfunction.
     Am J Physiol Heart Circ Physiol, 289(3): H1038-46. [Abstract] [Full-text]
145. Tempol therapy attenuates medial smooth muscle cell apoptosis and neointima formation after balloon catheter injury in carotid artery of diabetic rats.
     Am J Physiol Heart Circ Physiol, 289(3): H1047-53. [Abstract] [Full-text]
146. Physical activity and diabetes prevention.
     J Appl Physiol, 99(3): 1205-13. [Abstract] [Full-text]
147. Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease.
     J Appl Physiol, 99(3): 1193-204. [Abstract] [Full-text]
148. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.
     Arch Surg, 140(8): 735-44. [Abstract] [Full-text]
149. Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse.
     Adv Immunol, 87: 123-62. [Abstract] [Full-text]
150. The impact of type 2 diabetes and peripheral arterial disease on quality of life.
     J Vasc Nurs, 23(2): 61-6; quiz 67-8. [Abstract] [Full-text]
151. Achieving harmony with oneself: life with a chronic illness.
     Scand J Caring Sci, 19(3): 204-12. [Abstract] [Full-text]
152. Progression of macrovascular diseases is reduced in type 1 diabetic patients after more than 5 years successful combined pancreas-kidney transplantation in comparison to kidney transplantation alone.
     Transpl Int, 18(9): 1054-60. [Abstract] [Full-text]
153. Allosteric activation of protein phosphatase 2C by D-chiro-inositol-galactosamine, a putative mediator mimetic of insulin action.
     Biochemistry, 44(33): 11067-73. [Abstract] [Full-text]
154. Ethnic disparities: control of glycemia, blood pressure, and LDL cholesterol among US adults with type 2 diabetes.
     Ann Pharmacother, 39(9): 1489-501. [Abstract] [Full-text]
155. Glycemic monitoring in diabetics with sickle cell plus beta-thalassemia hemoglobinopathy.
     Ann Pharmacother, 39(9): 1557-60. [Abstract] [Full-text]
156. A proteomic study of the apolipoproteins in LDL subclasses in patients with the metabolic syndrome and type 2 diabetes.
     J Lipid Res, 46(9): 1999-2006. [Abstract] [Full-text]
157. Disrupted G1 to S phase clearance via cyclin signaling impairs liver tissue repair in thioacetamide-treated type 1 diabetic rats.
     Toxicol Appl Pharmacol, 207(2): 89-102. [Abstract] [Full-text]
158. Exercise without weight loss is an effective strategy for obesity reduction in obese individuals with and without Type 2 diabetes.
     J Appl Physiol, 99(3): 1220-5. [Abstract] [Full-text]
159. Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.
     Proc Natl Acad Sci U S A, 102(33): 11823-8. [Abstract] [Full-text]
160. Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction.
     Proc Natl Acad Sci U S A, 102(33): 11870-5. [Abstract] [Full-text]
161. Leptin improves insulin resistance and hyperglycemia in a mouse model of type 2 diabetes.
     Endocrinology, 146(9): 4024-35. [Abstract] [Full-text]
162. Trends in the quality of care and racial disparities in Medicare managed care.
     N Engl J Med, 353(7): 692-700. [Abstract] [Full-text]
163. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.
     N Engl J Med, 353(7): 663-70. [Abstract] [Full-text]
164. Systemic and periocular deliveries of plasminogen kringle 5 reduce vascular leakage in rat models of oxygen-induced retinopathy and diabetes.
     Curr Eye Res, 30(8): 681-9. [Abstract] [Full-text]
165. Adult-like but regressive increase of intima-media thickness and roughness in a child with type 1 diabetes.
     Pediatr Diabetes, 6(3): 161-4. [Abstract] [Full-text]
166. Possible impact of plasma RNase activity on immune dysfunction in juvenile diabetes mellitus.
     Pediatr Diabetes, 6(3): 155-60. [Abstract] [Full-text]
167. Aerobic exercise capacity in normal adolescents and those with type 1 diabetes mellitus.
     Pediatr Diabetes, 6(3): 145-9. [Abstract] [Full-text]
168. Newborn HLA-DR,DQ genotype screening: age- and ethnicity-specific type 1 diabetes risk estimates.
     Pediatr Diabetes, 6(3): 136-44. [Abstract] [Full-text]
169. Hyperglycemic hyperosmolar non-ketotic syndrome in children with type 2 diabetes*.
     Pediatr Diabetes, 6(3): 129-35. [Abstract] [Full-text]
170. Epidemics of type 1 diabetes in China.
     Pediatr Diabetes, 6(3): 122-8. [Abstract] [Full-text]
171. Do age and comorbidity affect intensity of pharmacological therapy for poorly controlled diabetes mellitus?
     J Am Geriatr Soc, 53(7): 1214-6. [Abstract] [Full-text]
172. Effect of blood pressure and diabetes mellitus on cognitive and physical functions in older adults: a longitudinal analysis of the advanced cognitive training for independent and vital elderly cohort.
     J Am Geriatr Soc, 53(7): 1154-61. [Abstract] [Full-text]
173. Synergy in polymicrobial infections in a mouse model of type 2 diabetes.
     Infect Immun, 73(9): 6055-63. [Abstract] [Full-text]
174. Elevated placental growth factor (PlGF) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
     Scand J Clin Lab Invest Suppl, 240: 73-9. [Abstract] [Full-text]
175. Standardization of HbA1c and Optimal Range of Monitoring.
     Scand J Clin Lab Invest Suppl, 240: 61-72. [Abstract] [Full-text]
176. Consequences of bias and imprecision in measurements of glucose and hba1c for the diagnosis and prognosis of diabetes mellitus.
     Scand J Clin Lab Invest Suppl, 240: 51-60. [Abstract] [Full-text]
177. Quality of guidelines for the laboratory management of diabetes mellitus.
     Scand J Clin Lab Invest Suppl, 240: 41-50. [Abstract] [Full-text]
178. Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic intervention.
     Scand J Clin Lab Invest Suppl, 240: 30-40. [Abstract] [Full-text]
179. A comprehensive review of interventions in the NOD mouse and implications for translation.
     Immunity, 23(2): 115-26. [Abstract] [Full-text]
180. Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine.
     J Neurochem, 94(5): 1402-10. [Abstract] [Full-text]
181. Vascular endothelial growth factor levels in vitreous and serum of patients with either proliferative diabetic retinopathy or proliferative vitreoretinopathy.
     Ophthalmic Res, 37(4): 188-90. [Abstract] [Full-text]
182. A novel, long-acting agonist of glucose-dependent insulinotropic polypeptide suitable for once-daily administration in type 2 diabetes.
     J Pharmacol Exp Ther, 314(3): 1187-94. [Abstract] [Full-text]
183. Effect of Dianex, a herbal formulation on experimentally induced diabetes mellitus.
     Phytother Res, 19(5): 409-15. [Abstract] [Full-text]
184. The effect of annatto on insulin binding properties in the dog.
     Phytother Res, 19(5): 433-6. [Abstract] [Full-text]
185. Role of zinc and zinc transporters in the molecular pathogenesis of diabetes mellitus.
     Med Hypotheses, 65(5): 887-92. [Abstract] [Full-text]
186. Therapeutic potentials of unicellular green alga Chlorella in advanced glycation end product (AGE)-related disorders.
     Med Hypotheses, 65(5): 953-5. [Abstract] [Full-text]
187. Approved IFCC recommendation on reporting results for blood glucose (abbreviated).
     Clin Chem, 51(9): 1573-6. [Abstract] [Full-text]
188. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
     N Engl J Med, 353(8): 782-92. [Abstract] [Full-text]
189. Oxidative damage to nuclear DNA in streptozotocin-diabetic rat liver.
     Clin Exp Pharmacol Physiol, 32(8): 663-6. [Abstract] [Full-text]
190. Improvement of insulin resistance by Acanthopanax senticosus root in fructose-rich chow-fed rats.
     Clin Exp Pharmacol Physiol, 32(8): 649-54. [Abstract] [Full-text]
191. Effects of administration of oral magnesium on plasma glucose and pathological changes in the aorta and pancreas of diabetic rats.
     Clin Exp Pharmacol Physiol, 32(8): 604-10. [Abstract] [Full-text]
192. The effect of periodontal therapy on uncontrolled type 2 diabetes mellitus in older subjects.
     Oral Dis, 11(5): 293-8. [Abstract] [Full-text]
193. Effect of L-carnitine on acetyl-CoA content and activity of blood platelets in healthy and diabetic persons.
     Clin Chem, 51(9): 1673-82. [Abstract] [Full-text]
194. Attenuation and delay of diabetic cataracts by antioxidants: effectiveness of pyruvate after onset of cataract.
     Ophthalmologica, 219(5): 309-15. [Abstract] [Full-text]
195. Screening for diabetic retinopathy by one-field, non-mydriatic, 45 degrees digital photography is inadequate.
     Ophthalmologica, 219(5): 292-6. [Abstract] [Full-text]
196. Validation of a modified version of the Brief Pain Inventory for painful diabetic peripheral neuropathy.
     J Vasc Nurs, 23(3): 97-104. [Abstract] [Full-text]
197. Impact of C-reactive protein on the likelihood of peripheral arterial disease in United States adults with the metabolic syndrome, diabetes mellitus, and preexisting cardiovascular disease.
     Am J Cardiol, 96(5): 655-8. [Abstract] [Full-text]
198. Ring chromosome 4 in a patient with early onset type 2 diabetes, deafness, and developmental delay.
     Am J Med Genet A, 137(2): 213-6. [Abstract] [Full-text]
199. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment.
     Muscle Nerve, 32(3): 351-6. [Abstract] [Full-text]
200. Role of histone and transcription factor acetylation in diabetes pathogenesis.
     Diabetes Metab Res Rev, 21(5): 416-33. [Abstract] [Full-text]
201. Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies.
     Diabetes Metab Res Rev, 21(5): 395-415. [Abstract] [Full-text]
202. Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 gene might be a risk factor for diabetic retinopathy in Slovene population (Caucasians) with type 2 diabetes and the Pro12Ala polymorphism of the PPARgamma gene is not.
     Diabetes Metab Res Rev, 21(5): 470-4. [Abstract] [Full-text]
203. Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes.
     Diabetes Metab Res Rev, 21(5): 448-58. [Abstract] [Full-text]
204. CKD progression and mortality among older patients with diabetes.
     Am J Kidney Dis, 46(3): 406-14. [Abstract] [Full-text]
205. Chronic administration of phosphodiesterase 5 inhibitor improves erectile and endothelial function in a rat model of diabetes.
     Int J Androl, 28(5): 260-6. [Abstract] [Full-text]
206. The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia.
     Trends Pharmacol Sci, 26(9): 477-84. [Abstract] [Full-text]
207. Bridging advanced glycation end product, receptor for advanced glycation end product and nitric oxide with hormonal replacement/estrogen therapy in healthy versus diabetic postmenopausal women: a perspective.
     Biochim Biophys Acta, 1745(2): 145-55. [Abstract] [Full-text]
208. The fusion of bone-marrow-derived proinsulin-expressing cells with nerve cells underlies diabetic neuropathy.
     Proc Natl Acad Sci U S A, 102(35): 12525-30. [Abstract] [Full-text]
209. Acute hypertensive encephalopathy with widespread small-vessel disease at MRI in a diabetic patient: pathogenetic hypotheses.
     Neuroradiology, 47(8): 599-603. [Abstract] [Full-text]

© 2004-2008 Diabetes Research Today. All Rights Reserved.